IRIS
MOSCHESE, VIVIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 209
EU - Europa 97
AS - Asia 65
AF - Africa 14
Totale 385
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 206
DE - Germania 47
IT - Italia 41
VN - Vietnam 36
CN - Cina 19
CI - Costa d'Avorio 14
SG - Singapore 5
IN - India 4
NL - Olanda 4
CA - Canada 3
SE - Svezia 2
CH - Svizzera 1
PH - Filippine 1
RO - Romania 1
UA - Ucraina 1
Totale 385
Salva come PNG Salva come JPEG
Città #
Chandler 71
Dong Ket 36
Des Moines 10
Boston 8
Lawrence 8
Nanjing 8
Napoli 8
Ashburn 6
Beijing 5
Schoenwalde 5
Chennai 4
Singapore 4
Falls Church 3
Millbury 3
Montesarchio 3
Princeton 3
Redwood City 3
Rietheim-Weilheim 3
Wilmington 3
Woodbridge 3
Amsterdam 2
Fairfield 2
Freiburg im Breisgau 2
Hebei 2
Houston 2
Krefeld 2
Bad Durrheim 1
Casapulla 1
Changsha 1
Cologne 1
Coquitlam 1
Duino-Aurisina 1
Gesualdo 1
Ghedi 1
Hanover 1
Harbin 1
Lissone 1
Los Angeles 1
Milan 1
Mississauga 1
Nanchang 1
Nola 1
Ottawa 1
Rome 1
San Mateo 1
Shenyang 1
Totale 229
Salva come PNG Salva come JPEG
Nome #
Clinical, Immunological, and Functional Characterization of Six Patients with Very High IgM Levels 55
Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study 44
Follow-up and outcome of symptomatic partial or absolute IgA deficiency in children 40
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 37
X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world 36
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 31
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 27
Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS) 26
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies 25
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 24
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 23
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 22
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 21
Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET) 4
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 3
Totale 418
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 2 0
2019/202046 22 0 0 0 1 1 1 1 2 8 7 3
2020/202167 4 0 1 4 6 0 6 0 1 1 5 39
2021/202267 0 0 1 3 3 5 1 0 0 6 24 24
2022/2023146 13 14 7 9 21 14 0 10 14 2 12 30
2023/202475 3 12 26 5 0 2 1 17 2 2 5 0
Totale 418